Specification
Catalog# EM0401
Vimentin Mouse Monoclonal Antibody [D4-B11]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
IF-Tissue
-
IHC-Fr
-
IP
-
Human
-
Mouse
-
Rat
-
unconjugated
Overview
Product Name
Vimentin Mouse Monoclonal Antibody [D4-B11]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human Vimentin.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IHC-P, FC, IF-Tissue, IHC-Fr, IP
Molecular Weight
Predicted band size: 54 kDa
Positive Control
293T cell lysate, HeLa cell lysate, Jurkat cell lysate, C2C12 cell lysate, NIH/3T3 cell lysate, C6 cell lysate, human kidney tissue, human tonsil tissue, human skin tissue, human colon carcinoma tissue, human stomach carcinoma tissue, human liver tissue, human appendix tissue, human endometrium tissue, mouse kidney tissue, rat colon tissue, HeLa, C2C12, C6, Huh7.
Conjugation
unconjugated
Clone Number
D4-B11
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000-1:10,000
-
IF-Cell
-
1:100-1:500
-
IHC-P
-
1:500-1:1,000
-
FC
-
1:500-1:1,000
-
IF-Tissue
-
1:200-1:500
-
IHC-Fr
-
1:500-1:1,000
-
IP
-
Use at an assay dependent concentration
Target
Function
Vimentin is a structural protein that in humans is encoded by the VIM gene. Its name comes from the Latin vimentum which refers to an array of flexible rods. Vimentin is a type III intermediate filament (IF) protein that is expressed in mesenchymal cells. IF proteins are found in all animal cells[6] as well as bacteria. Intermediate filaments, along with tubulin-based microtubules and actin-based microfilaments, comprises the cytoskeleton. All IF proteins are expressed in a highly developmentally-regulated fashion; vimentin is the major cytoskeletal component of mesenchymal cells. Because of this, vimentin is often used as a marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal transition (EMT) during both normal development and metastatic progression. Vimentin plays a significant role in supporting and anchoring the position of the organelles in the cytosol. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally.
Background References
1. "Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process." Goto H., Yasui Y., Kawajiri A., Nigg E.A., Terada Y., Tatsuka M., Nagata K., Inagaki M. J. Biol. Chem. 278:8526-8530(2003)
2. "Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments." Eriksson J.E., He T., Trejo-Skalli A.V., Harmala-Brasken A.-S., Hellman J., Chou Y.-H., Goldman R.D. J. Cell Sci. 117:919-932(2004)
3. "The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network." Ahmed B.A., Bukhari I.A., Jeffus B.C., Harney J.T., Thyparambil S., Ziu E., Fraer M., Rusch N.J., Zimniak P., Lupashin V., Tang D., Kilic F. PLoS ONE 4:E4730-E4730(2009)
Sequence Similarity
Belongs to the intermediate filament family.
Tissue Specificity
Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines.
Post-translational Modification
Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments. Phosphorylated at Ser-56 by CDK5 during neutrophil secretion in the cytoplasm. Phosphorylated by STK33. Phosphorylated on tyrosine residues by SRMS.; O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status.; S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex.
Subcellular Location
Cytoplasm
Synonyms
CTRCT30 antibody
Epididymis luminal protein 113 antibody
FLJ36605 antibody
HEL113 antibody
VIM antibody
VIME_HUMAN antibody
Vimentin antibody
Images
-
☑ Knockout (KO)
Western blot analysis of Vimentin with anti-Vimentin antibody [D4-B11] (EM0401) at 1/5,000 dilution.
Lane 1: Wild-type Hela whole cell lysate (20 µg).
Lane 2: Vimentin knockout Hela whole cell lysate (20 µg).
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (EM0401, 1/5,000) and Loading control antibody (Rabbit anti-GAPDH , ET1601-4, 1/10,000) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Mouse IgG-HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of Vimentin on different lysates with Mouse anti-Vimentin antibody (EM0401) at 1/5,000 dilution.
Lane 1: 293T cell lysate
Lane 2: HeLa cell lysate
Lane 3: Jurkat cell lysate
Lane 4: C2C12 cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: C6 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time:15 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM0401) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunofluorescence analysis of paraffin-embedded human kidney tissue labeling Vimentin (EM0401) and NPHS2 (ET7107-34).
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/400 dilution and NPHS2 (ET7107-34, red) at 1/100 dilution overnight at 4 ℃, washed with PBS.
iFluor™ 488 conjugate-Goat anti-Mouse IgG (HA1125) and iFluor™ 594 conjugate-Goat anti-Rabbit IgG (HA1122) were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunofluorescence analysis of paraffin-embedded human tonsil tissue labeling Vimentin (EM0401) at 1/200 dilution and Cytokeratin 5 (ET1610-43) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/200 dilution and Cytokeratin 5 (ET1610-43, red) at 1/200 dilution at +4℃ overnight, washed with PBS. Alexa Fluor®488 conjugate-Goat anti-Mouse IgG and Alexa Fluor®594 conjugate-Goat anti-Rabbit IgG were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunofluorescence analysis of paraffin-embedded human skin tissue labeling Vimentin (EM0401) at 1/200 dilution and Cytokeratin 5 (ET1610-43) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/200 dilution and Cytokeratin 5 (ET1610-43, red) at 1/200 dilution at +4℃ overnight, washed with PBS. Alexa Fluor®488 conjugate-Goat anti-Mouse IgG and Alexa Fluor®594 conjugate-Goat anti-Rabbit IgG were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-Vimentin antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401, 1/800) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human stomach carcinoma tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human liver tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human appendix tissue with Mouse anti-Vimentin antibody (EM0401) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human endometrium tissue with Mouse anti-Vimentin antibody (EM0401) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Mouse anti-Vimentin antibody (EM0401) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat colon tissue with Mouse anti-Vimentin antibody (EM0401) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Vimentin was immunoprecipitated from 0.2 mg HeLa cell lysate with EM0401 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using EM0401 at 1/1,000 dilution. Anti-Mouse IgG for IP Nano-secondary antibody (NBI02H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: HeLa cell lysate (input)
Lane 2: EM0401 IP in HeLa cell lysate
Lane 3: Mouse IgG instead of EM0401 in HeLa cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 3 minutes; ECL: K1801 -
Application: IHC-Fr
Species: Mouse
Site: Colon
Sample: Frozen section
Antibody concentration: 1/500
Antigen retrieval: Not required -
Immunocytochemistry analysis of HeLa cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C2C12 cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of Huh7 cells labeling Vimentin with Rabbit anti-Vimentin antibody (EM0401) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Vimentin antibody (EM0401) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HeLa cells labeling Vimentin.
Cells were fixed and permeabilized.Then stained with the primary antibody (EM0401, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Seco-neokadsuranic acid A antagonizes SH3BP1 to suppress hepatocellular carcinoma progression through PPAR pathway activation
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157824
IF: 8.3
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Jan
-
Tom70 prevents fibrotic activation of aortic valve interstitial cells via EPA-activated Autophagic flux
Journal: Biochimica Et Biophysica Acta (Bba) - Molecular Basis Of Disease
DOI: 10.1016/j.bbadis.2025.168063
IF: 4.2
Application: IF
Reactivity: Rat
Publish date: 2025 Sept
-
Cardiomyocyte USP20 alleviates septic cardiomyopathy by deubiquitinating and inhibiting NLRP3 activity
Journal: Clinical And Translational Medicine
DOI: 10.1002/ctm2.70494
IF: 6.8
Application: IF-Tissue
Reactivity: Mouse
Publish date: 2025 Oct
-
ACOD1/Itaconate regulates trophoblast function through the PI3K/Akt/FOLR1 axis to participate in the pathogenesis of recurrent spontaneous abortion
Journal: BIOCHEMICAL PHARMACOLOGY
DOI: 10.1016/j.bcp.2025.117405
IF: 5.6
Application: IHC
Reactivity: Mouse
Publish date: 2025 Oct
-
Blastocyst-Secreted miR-519d-3p Modulated the Cell Viability, Apoptosis and Migration of Human Endometrial Stromal Cells by Targeting HIF1α
Journal: Reproductive Sciences
DOI: 10.1007/s43032-025-01988-3
IF: 2.5
Application: IF-Cell
Reactivity: Human
Publish date: 2025 Oct
-
TGF-β1 Up-Regulates PLAU Expression to Promote Invasion and Migration of Oral Squamous Cell Carcinoma
Journal: Journal of Oral Pathology & Medicine
DOI: 10.1111/jop.70091
IF: 2.3
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing
Journal: Autophagy
DOI: 10.1080/15548627.2025.2508546
IF: 14.6
Application: IF
Reactivity: Mouse
Publish date: 2025 May
-
Integrated analysis of single-cell RNA-seq and ATAC-seq in lens epithelial cells: Unveiling the role of ATF6 as a key transcription factor
Journal: Genes & Diseases
DOI: 10.1016/j.gendis.2025.101610
IF: 9.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
The RNA-binding protein DDX39B promotes colorectal adenocarcinoma progression by stabilizing DCLK1
Journal: HUMAN MOLECULAR GENETICS
DOI: 10.1093/hmg/ddaf110
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Magnesium ions attenuate tendon graft fibrosis during its ligamentization after ACL reconstruction through modulation of fibroblast to myofibroblast trans-differentiation by promoting PGE2 secretion
Journal: Bioactive Materials
DOI: 10.1016/j.bioactmat.2025.06.019
IF: 20.3
Application: FC
Reactivity: Rat
Publish date: 2025 Jun
-
Inhalable Chemotactic Liposome for Targeted Modulation of Pulmonary Pre-Metastatic Niche
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202419583
IF: 19
Application: IF-Tissue
Reactivity: Mouse
Publish date: 2025 Jan
-
JOSD2 alleviates hypertensive renal disease through deubiquitinating AKT in renal tubular epithelial cells
Journal: Cellular Signalling
DOI: 10.1016/j.cellsig.2025.112330
IF: 3.7
Application: WB
Reactivity: Mouse,Rat
Publish date: 2025 Dec
-
DLP 3D-printed biomimetic periodontium composite with xenogenic treated dentin matrix modulates periodontal regeneration and inflammatory response
Journal: Biomaterials Advances
DOI: 10.1016/j.bioadv.2025.214668
IF: 6
Application: IF-cell
Reactivity: Rat
Publish date: 2025 Dec
-
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING
Journal: Acta Pharmaceutica Sinica B
DOI: 10.1016/j.apsb.2025.03.051
IF: 14.7
Application: IF
Reactivity: Mouse
Publish date: 2025 Apr
-
The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment
Journal: Placenta
DOI: 10.1016/j.placenta.2025.04.010
IF: 3
Application: IF
Reactivity: Rat
Publish date: 2025 Apr
-
Mechanism of Modified Tongyou Decoction and Its Separated Formulas Inhibiting Vasculogenic Mimicry in Esophageal Cancer TE-1 Cells via NF-κB/HIF-1α Axis
Journal: Integrative Cancer Therapies
DOI: 10.1177/15347354251332590
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Fractionated irradiation induces radioresistant oral carcinoma cells with enhanced malignant phenotypes
Journal: Archives Of Oral Biology
DOI:
IF: 3
Application: WB
Reactivity: Human
Publish date: 2024 May
-
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
Journal: Nature Communications
DOI:
IF: 16.6
Application: IF
Reactivity: Mouse
Publish date: 2024 Mar
-
RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB,IHC-P,IF
Reactivity: Mouse
Publish date: 2024 Mar
-
A nano-platform combats the "attack" and "defense" of cytoskeleton to block cascading tumor metastasis
Journal: Journal Of Controlled Release
DOI: 10.1016/j.jconrel.2024.01.069
IF: 10.5
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
Journal: Cell Communication And Signaling
DOI: 10.1186/s12964-024-01955-6
IF: 8.2
Application: IF
Reactivity: Mouse
Publish date: 2024 Dec
-
Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen R
Journal: Redox Biology
DOI:
IF: 11.4
Application: IF
Reactivity: Mouse
Publish date: 2024 Apr
-
Sclareol attenuates liver fibrosis through SENP1‐mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling
Journal: Phytotherapy Research
DOI:
IF: 7.2
Application: WB
Reactivity: Rat
Publish date: 2023 May
-
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells
Journal: Signal Transduction And Targeted Therapy
DOI:
IF: 38.104
Application: WB
Reactivity: Human
Publish date: 2023 May
-
TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy
Journal: Theranostics
DOI:
IF: 12.4
Application: IF-Cell
Reactivity: Mouse
Publish date: 2023 Jul
-
SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma
Journal: Thoracic Cancer
DOI:
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes
Journal: Nature Cardiovascular Research
DOI: 10.1038/s44161-023-00313-y
IF: 0
Application: IHC-P
Reactivity: Mouse
Publish date: 2023 Aug
-
Canonical and noncanonical pyroptosis are both activated in periodontal inflammation and bone resorption
Journal: Journal Of Periodontal Research
DOI: 10.1111/jre.13055
IF: 3.946
Application: IF
Reactivity: Human
Publish date: 2022 Sept
-
CD166-specific CAR-T cells potently target colorectal cancer cells
Journal: Translational Oncology
DOI:
IF: 4.803
Application: WB
Reactivity: Human
Publish date: 2022 Oct
-
Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis
Journal: FASEB Journal
DOI:
IF: 5.834
Application: WB
Reactivity: Human
Publish date: 2022 Jun
-
miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1. BMC cancer, 20(1), 1028.
Journal: BMC Cancer
DOI:
IF: 3.153
Application: WB
Reactivity: Human
Publish date: 2020 Oct
-
Long term exposure to γ‑rays induces radioresistance and enhances the migration ability of bladder cancer cells
Journal: Molecular Medicine Reports
DOI: 10.3892/mmr.2018.9605
IF: 1.922
Application: WB
Reactivity: Human
Publish date: 2018 Oct
Products with the same target and pathway
Vimentin Recombinant Rabbit Monoclonal Antibody [PDH0-01]
Application: WB,IHC-P,IF-Cell,FC,IF-Tissue,mIHC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 647 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 647
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05] - BSA and Azide free
Application: WB,IHC-P,IHC-Fr,IF-Tissue,IF-Cell,FC,IP
Reactivity: Human,Mouse,Rat,Cynomolgus monkey,Pig
Conjugate: unconjugated
Vimentin Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Vimentin Recombinant Mouse Monoclonal Antibody [A6-C1-R] - BSA and Azide free
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: WB,IHC-P,IHC-Fr,IF-Tissue,IF-Cell,FC,IP
Reactivity: Human,Mouse,Rat,Cynomolgus monkey,Pig
Conjugate: unconjugated
Vimentin Recombinant Antibody - Rat IgG1 (Chimeric)
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Phospho-Vimentin (S39) Recombinant Rabbit Monoclonal Antibody [JE43-26]
Application: WB,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 488 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 488
Vimentin Recombinant Mouse Monoclonal Antibody [A6-C1-R]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Mouse Monoclonal Antibody [A6-C1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
